137 related articles for article (PubMed ID: 35686499)
1. Dysregulated Th1 cells in lung squamous cell carcinoma.
Wang J; Zhou J; Zhou Q; Qi Y; Zhang P; Yan C; Ren X
J Leukoc Biol; 2022 Dec; 112(6):1567-1576. PubMed ID: 35686499
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analyses of a CD8
Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma.
Shan G; Minchao K; Jizhao W; Rui Z; Guangjian Z; Jin Z; Meihe L
J Pharm Biomed Anal; 2023 May; 229():115346. PubMed ID: 37001272
[TBL] [Abstract][Full Text] [Related]
4. [Exploration of the Perturbation of PKIG in Lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
[TBL] [Abstract][Full Text] [Related]
5. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.
Yin Y; Wang Y; Wang C; Zhang Y; Qi A; Song J; Xu L; Yang W; Jiao L
J Ethnopharmacol; 2024 May; 326():117984. PubMed ID: 38428661
[TBL] [Abstract][Full Text] [Related]
6. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
Zhang T; Yang H; Sun B; Yao F
Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
[TBL] [Abstract][Full Text] [Related]
7. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
8. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML; Zhou W; Peebles RS
J Virol; 2014 Sep; 88(17):9655-72. PubMed ID: 24920804
[TBL] [Abstract][Full Text] [Related]
9. Intestinal irradiation and fibrosis in a Th1-deficient environment.
Linard C; Billiard F; Benderitter M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):266-73. PubMed ID: 22336200
[TBL] [Abstract][Full Text] [Related]
10. Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma.
Hao B; Dong H; Xiong R; Song C; Xu C; Li N; Geng Q
Comput Biol Med; 2024 Mar; 171():108183. PubMed ID: 38422959
[TBL] [Abstract][Full Text] [Related]
11. Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma.
Yu T; Nie FQ; Zhang Q; Yu SK; Zhang ML; Wang Q; Wang EX; Lu KH; Sun M
Cell Death Dis; 2024 Jan; 15(1):12. PubMed ID: 38182561
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma.
Guo Q; Wu CY; Jiang N; Tong S; Wan JH; Xiao XY; Mei PY; Liu HS; Wang SH
Front Immunol; 2022; 13():986447. PubMed ID: 36544782
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
[TBL] [Abstract][Full Text] [Related]
15. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
Deng X; Wang Z; Luo Y; Li Z; Chen L
Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage.
Du N; Zhang B; Zhang Y
Can Respir J; 2023; 2023():4533504. PubMed ID: 37547297
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma.
Tian H; Wei R; Xiao C; Fan T; Che Y; Liu T; Zheng B; Li C; He J
BMC Pulm Med; 2024 Jan; 24(1):53. PubMed ID: 38273291
[TBL] [Abstract][Full Text] [Related]
18. [Impact of cyclosporine A on the expression of T-bet, GATA-3, relevant signal transduction molecules, cytokine and Th1/Th2 balance in patients with chronic aplastic anemia].
Li J; Zhou YM; Hu MH; Sun WL; Xue ZZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1211-9. PubMed ID: 21129263
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the presence of Th1 response through T-bet and IFN-gamma immunohistochemical expression in lower lip and oral tongue squamous cell carcinomas.
Rodrigues RR; Freitas VS; Alves PM; Almeida Freitas R; Souza LB; Andrade Santos PP
Pathol Res Pract; 2024 Jan; 253():155010. PubMed ID: 38101155
[TBL] [Abstract][Full Text] [Related]
20. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
